[1]
Iqbal, F. 2023. Enhancing the effectiveness of Chimeric Antigen Receptor (CAR) T cells against tumors through CRISPR/Cas9-mediated PD-1 disruption. International journal of health sciences. 7, S1 (Jul. 2023), 1836–1850. DOI:https://doi.org/10.53730/ijhs.v7nS1.14397.